CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax of -$63.00 million as of 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax · last filed 2026-02-18
- 2025-12-27: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax -$63.00M.
- 2024-12-28: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax -$69.34M.
- 2023-12-30: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax -$58.85M.
- 2022-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax -$54.51M.
| Period end | Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax |
|---|---|
| 2025-12-27 | -$63.00M 10-K · filed 2026-02-18 |
| 2024-12-28 | -$69.34M 10-K · filed 2026-02-18 |
| 2023-12-30 | -$58.85M 10-K · filed 2026-02-18 |
| 2022-12-31 | -$54.51M 10-K · filed 2025-02-19 |
| 2021-12-25 | -$82.75M 10-K · filed 2023-02-22 |
| 2020-12-26 | -$82.91M 10-K · filed 2022-02-16 |
| 2019-12-28 | -$116.93M 10-K · filed 2021-02-17 |
| 2018-12-29 | -$93.48M 10-K · filed 2020-02-11 |
| 2017-12-30 | -$94.70M 10-K · filed 2019-02-13 |
| 2016-12-31 | -$123.74M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |